Biotechnology
Ascentage Pharma Announces Clearances for Three Phase Ib/II Clinical Studies of APG-2575 in China and the U.S., Beginning Simultaneous Clinical Development in Three Hematologic Malignancy Indications
SUZHOU, China and ROCKVILLE, MD., March 9, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that two clinical studies of...
2020-03-09 20:00
1990
Global Cord Blood Corporation to Report Third Quarter and First Nine Months Fiscal 2020 Financial Results
HONG KONG, March 9, 2020 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that it plans to release unaudited financial ...
2020-03-09 19:00
9212
Berkeley Lights Launches T Cell Receptor Sequencing Kit to Increase Efficiency of T Cell Receptor Discovery
The T Cell Receptor Sequencing Kit (TCRseq Kit) allows users of Berkeley Lights platforms to more efficiently identify, recover, and sequence T cells of interest EMERYVILLE, Calif., March 6, 2020 /PRNewswire/ -- Today, Berkeley Lights, a leader in cell selection, launched their new T Cell Recept...
2020-03-06 03:01
3531
Innovent Biologics Announces First Patient Dosed in the Pivotal Registrational Trial of Pemigatinib in Patients with Advanced Cholangiocarcinoma in China
SUZHOU, China, March 4, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent" or "the Company") (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines for the treatment of cancer, autoimmune, metabolic and other major diseases, today an...
2020-03-04 08:00
5901
Philips Applauded by Frost & Sullivan for its Thought and Technology Leadership and Patient-centered Innovation in the Radiology Market
Philips leverages state-of-the-art technologies to optimize its broad suite of tools, providing timely insights to support radiologists' workflows SANTA CLARA, California, March 3, 2020 /PRNewswire/ -- Based on its recent analysis of the global market for Artificial Intelligence (AI) for enhanced...
2020-03-03 22:00
1500
CROMSOURCE Announces a Significant Milestone in Digital Management of Its Projects in Cooperation with Techorizon
VERONA, Italy, March 3, 2020 /PRNewswire/ -- CROMSOURCE announced today the achievement of a significant milestone in the digital management of clinical research projects for their clients. InFebruary 2020 CROMSOURCE initiated the 1000th trial to be managed within the advanced TheClinical digital...
2020-03-03 20:00
2658
NAGASE to Launch Glucosyl Naringin, Citrus-derived Anti-aging Cosmetic Ingredient, on March 31
TOKYO, March 3, 2020 /PRNewswire/ -- NAGASE & CO., LTD. of Tokyo will start on March 31 sales of Glucosyl Naringin, an anti-aging cosmetic ingredient that promotes the production of elastin, an extracellular matrix protein involved in the maintenance of skin elasticity and the formation of elasti...
2020-03-03 16:00
1579
ERBITUX® Approved for First-line Use in China in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN)
Approval is for ERBITUX® in combination with platinum-based therapy with fluorouracil for the first-line treatment of R/M SCCHN Pivotal Phase III study shows significant improvements with ERBITUX® in combination with platinum-based therapy with fluorouracil in response rate, disease progression ...
2020-03-02 15:02
5177
Researchers Worldwide Are Using Berkeley Lights' Beacon Platform To Combat COVID-19
Berkeley Lights' proprietary technology, the Beacon® optofluidic platform, is currently used by researchers across three continents—the U.S.,China, and Australia—to help them find solutions for the Coronavirus EMERYVILLE, Calif., Feb. 29, 2020 /PRNewswire/ -- Berkeley Lights, Inc., a leader in c...
2020-02-29 01:00
3774
KAHR Medical Raises $18 Million in Private Funding Round
Funds will be used for advancing the Company's next generation immuno-oncology
drug candidates, including lead anti-CD47 product for the treatment of solid
tumors through Phase I/II study in addition to advancing preclinical pipeline
JERUSALEM, Feb. 26, 2020 /PRNewswire/ -- KAHR Medical
2020-02-26 08:30
2820
InDex Pharmaceuticals Publishes Mechanism of Action Data for Cobitolimod in Scientific Journal
STOCKHOLM, Feb. 25, 2020 /PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) today announced the publication of scientific data on the mechanism of action of cobitolimod, the company's lead drug candidate in development for the treatment of moderate to severe ulcerative colitis. The paper, pu...
2020-02-25 15:26
1273
S-CELL Becomes the First in Asia to Introduce Consumer Epigenetics Testing and is the Most Advanced Test in the World
HONG KONG, Feb. 21, 2020 /PRNewswire/ -- S-CELL, in partnership with Chronomics, is the first company inAsia to introduce Healthspan, the most advanced epigenetic testing service in the world. Chronomics was established in 2017 and later officially launched the epigenetics testing kit in hopes to...
2020-02-21 09:20
2222
Hummingbird Bioscience Announces Agreement with Mycenax Biotech for Production of Anti-VISTA Antibody HMBD-002 for Cancer Clinical Trial
HOUSTON, Feb. 20, 2020 /PRNewswire/ -- Hummingbird Bioscience, an innovative biotherapeutics company pioneering the discovery of new breakthrough antibody therapeutics for difficult-to-treat conditions, today announced it has signed an agreement with Mycenax Biotech for the production of material...
2020-02-20 15:15
1596
Nimble Announces Collaboration with Genentech to Discover and Develop Novel Peptide-Based Therapeutics
MADISON, Wisconsin, Feb. 20, 2020 /PRNewswire/ -- Nimble Therapeutics, Inc. today announced a multi-year collaboration with Genentech, a member of the Roche Group, to accelerate discovery and development of novel peptide-based medicines for targets across a range of diseases. The collaboration w...
2020-02-20 01:00
1978
NeuroVive Pharmaceutical AB Year End Report January - December 2019
STOCKHOLM, Feb. 19, 2020 /PRNewswire/ -- Important events in 2019 KL1333 * NeuroVive enrolls first subject in its European KL1333 phase Ia/b clinical study * NeuroVive initiates second part of its ongoing KL1333 Phase Ia/b clinical study * NeuroVive compl...
2020-02-19 16:08
6300
Chinese Scientist Unite Together to Tackle With COVID-19
BEIJING, Feb. 19, 2020 /PRNewswire/ -- Reported by Science & Technology Daily: As to the battle against the COVID-19, Chinese Ministry of Science and Technology (MOST) has been launched the program of "Dealing With the Outbreak of COVID-19 Using Science and Technology", a program including four b...
2020-02-19 05:59
2162
Covaris launches novel viral RNA extraction kits for swab sample collection devices
- Covaris announced new kits for efficient viral RNA extraction from sterile, synthetic swabs - Covaris is supporting customers evaluating kits as a key component in the development of accurate COVID-19 virus detection assays WOBURN, Massachusetts, Feb. 18, 2020 /PRNewswire/ -- Covaris, Inc. tod...
2020-02-18 23:00
2441
Global Healthcare to Soar Above $2 Trillion in 2020 with Consumerism and Outcome-based Care Models
High adoption of annuity-based reimbursement programs by payers and therapy manufacturers will unlock the potential of gene therapies, finds Frost & Sullivan SANTA CLARA, California, Feb. 18, 2020 /PRNewswire/ -- Despite rising trade tension and a sluggish economic outlook for 2020, the global h...
2020-02-18 20:03
3258
WuXi Vaccines Signed Long-Term Vaccine Manufacturing Contract with a Global Vaccine Leader
SHANGHAI, Feb. 18, 2020 /PRNewswire/ -- WuXi Vaccines, a new vaccine Contract Development and Manufacturing Organization (CDMO) established between WuXi Biologics (stock code: 2269.HK) and Shanghai Hile Bio-technology (stock code: 603718.SH) announced that it has entered into a strategic partners...
2020-02-18 18:18
4367
Seegene launches KFDA Approved COVID-19 Assay
SEOUL, South Korea, Feb. 18, 2020 /PRNewswire/ -- Korea Centers for Disease Control & Prevention notified Seegene Inc. (096530.KQ) that Korea Ministry of Food and Drug Safety (MFDS; Former KFDA) approved its novel coronavirus (COIVD-19) Real-time PCR assay for the Emergency Use, following the rec...
2020-02-18 08:00
4061
Week's Top Stories
Most Reposted
Going Global: DCITS Embarks on International Expansion at Singapore Fintech Festival
[Picked up by 313 media titles]
2024-11-12 09:00
DKSH Healthcare and Euris Unveil CRM & MCE Platform "ConnectPlus" to Revolutionize APAC Healthcare Distribution
[Picked up by 293 media titles]
2024-11-13 09:00
Sobot Introduces its All-in-One Solution at GITEX Global 2024
[Picked up by 291 media titles]
2024-11-12 11:00
Ubiqconn Technology to Showcase Latest Marine Solutions at the 2024 International WorkBoat Show in New Orleans
[Picked up by 289 media titles]
2024-11-11 21:00
Transformation of Asia's Process Industries To Get A Boost Through Region's First Dedicated Process Technology Show
[Picked up by 279 media titles]
2024-11-12 16:00
Most Read
Ubiqconn Technology to Showcase Latest Marine Solutions at the 2024 International WorkBoat Show in New Orleans
2024-11-11 21:00
5629
DND International Eye Hospital: Pioneering SMILE Pro Surgery & Leading the Trend of Refractive Surgery Tourism in Vietnam
2024-11-08 20:11
5565
HOIANA RESORT & GOLF LAUNCHES PREMIUM HOIANA PICKLEBALL COURT
2024-11-08 00:18
5440
Going Global: DCITS Embarks on International Expansion at Singapore Fintech Festival
2024-11-12 09:00
5254